Envision Healthcare Corporation (NYSE:EVHC) had its price target trimmed by Oppenheimer Holdings, Inc. from $77.00 to $40.00 in a report published on Thursday. The firm currently has an outperform rating on the stock.

EVHC has been the subject of several other reports. Mizuho decreased their price objective on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a neutral rating for the company in a report on Wednesday, August 9th. Zacks Investment Research downgraded shares of Envision Healthcare Corporation from a hold rating to a strong sell rating in a research report on Tuesday, October 24th. Citigroup Inc. downgraded shares of Envision Healthcare Corporation from a buy rating to a neutral rating and set a $31.00 target price on the stock. in a research report on Thursday. BidaskClub downgraded shares of Envision Healthcare Corporation from a sell rating to a strong sell rating in a research report on Thursday, August 17th. Finally, Bank of America Corporation reduced their target price on shares of Envision Healthcare Corporation from $72.00 to $60.00 and set a buy rating on the stock in a research report on Monday, October 9th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus target price of $49.21.

Envision Healthcare Corporation (EVHC) traded down $0.21 during trading hours on Thursday, reaching $27.04. 4,795,013 shares of the company were exchanged, compared to its average volume of 5,488,916. The company has a quick ratio of 2.82, a current ratio of 3.01 and a debt-to-equity ratio of 0.89. Envision Healthcare Corporation has a 52 week low of $26.56 and a 52 week high of $74.75. The company has a market cap of $3,267.14, a price-to-earnings ratio of 8.35, a P/E/G ratio of 0.57 and a beta of 0.69.

Envision Healthcare Corporation (NYSE:EVHC) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $2.03 billion. During the same quarter last year, the company posted $1.13 earnings per share. The firm’s revenue for the quarter was up 142.0% compared to the same quarter last year. research analysts predict that Envision Healthcare Corporation will post 3.12 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/oppenheimer-holdings-inc-trims-envision-healthcare-corporation-evhc-target-price-to-40-00/1681328.html.

Envision Healthcare Corporation announced that its board has approved a share repurchase program on Monday, September 18th that permits the company to buyback $250.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 4.5% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s management believes its shares are undervalued.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Commonwealth Bank of Australia raised its stake in Envision Healthcare Corporation by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after acquiring an additional 410 shares during the period. LMR Partners LLP bought a new stake in Envision Healthcare Corporation during the 2nd quarter worth approximately $205,000. Cutter & CO Brokerage Inc. raised its stake in Envision Healthcare Corporation by 11.1% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after acquiring an additional 367 shares during the period. Flinton Capital Management LLC raised its stake in Envision Healthcare Corporation by 18.7% during the 2nd quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock worth $280,000 after acquiring an additional 704 shares during the period. Finally, HighTower Advisors LLC raised its stake in Envision Healthcare Corporation by 5.6% during the 1st quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock worth $274,000 after acquiring an additional 240 shares during the period.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.